The Mycobacterium tuberculosis enzyme Rv2275 catalyzes the formation of cyclo(L-Tyr-L-Tyr) using two molecules of Tyr-tRNA Tyr as substrates. The three-dimensional structure of Rv2275 was determined to 2.0 Å resolution, revealing that Rv2275 is structurally related to the class Ic aminoacyl-tRNA-synthetase family of enzymes. Mutagenesis and radioactive labeling suggests a covalent intermediate in which L-tyrosine is transferred from Tyr-tRNA Tyr to an active site serine (S88) by transesterification and with E233 serving as a critical base catalyzing dipeptide bond formation.
tuberculosis has a chromosomally encoded AlbC homolog (Rv2275) exhibiting 26% sequence identity to AlbC. Recombinant M. tuberculosis Rv2275 catalyzed the Tyr-tRNAdependent formation of cYY in E. coli cell lysates 9 . In M. tuberculosis, the adjacent gene encodes a cytochrome P450 (Rv2276) that catalyzes C-C bond formation between the carbons ortho to the phenolic hydroxyl of cYY, producing what we term mycocyclosin (Fig.  1a) 10 . Rv2276 was found to be an essential M. tuberculosis gene and it was suggested that either mycocyclosin was essential, or that the overproduction of cYY is toxic 10 , 11 .
The crystal structure of Rv2275 was solved at a resolution of 2.0 Å (Supplementary Table  1 ,2; Supplementary methods). The structural model consists of the entire Rv2275 sequence minus forty-eight N-terminal residues (1-48), five C-terminal residues (285-289) and a loop between α6 and α7 (residues 212-216), which were not observed in electron density maps. Rv2275 exhibits a single domain 3-layer βαβ structure with a Rossmann fold ( Fig. 1b;  Supplementary Fig. 1 ). The core consists of a mostly parallel β-sheet bound on either side by helices. A structural homology search by secondary-structure matching (SSM) 12 identified Rv2275 as being structurally similar to the catalytic domains of tyrosyl and tryptophanyltRNA synthetases (class-Ic aa-tRNA synthetases). The top scoring result was the tyrosyltRNA synthetases from Methanococcus jannaschii (MjTyrRS; PDBID=1J1U) 13 , with an r.m.s.d of 3.24 Å over 167 matched Cα positions, and 10% sequence identity (Fig. 1c) . Rv2275 lacks the anticodon recognition domain typically found in aa-tRNA synthetases. Both Rv2275 and class Ic tRNA-synthetases are dimers, however they have significantly different dimer interfaces ( Supplementary Fig 2) .
Class I aa-tRNA synthetases contain an N-terminally located HIGH sequence that interacts with ATP. The HIGH sequence motif is located at the β2/α3 loop in an "open" conformation, held by interactions with α5. In Rv2275, the corresponding loop (β3/α2) lacks the same interactions with the corresponding helix but instead folds back on itself, with N91, Y93 and F94 completely occupying the position corresponding to the ATP binding site ( Fig.  1b; Supplementary Fig. 3 ). These interactions are most likely essential to the CDPS active site architecture, as the position and interaction of two crucial catalytic residues, S88 (β3/α2 loop) and Y253 (β6) (see below) are strongly influenced by the conformation of the β3/α2 loop.
There is very low sequence identity between the members of the CDPS family, with most exhibiting less than 30% overall sequence identity ( Supplementary Fig. 4) . Six of the twelve completely conserved residues are clustered near a surface accessible pocket that roughly corresponds to the amino acid binding pocket of class I aa-tRNA synthetases (Fig. 1d) 9 . The base of the pocket consists of mostly hydrophobic residues (V84, G86, M170, L236, F237) with the exception of N251. Most of the strictly conserved residues in the substrate-binding pocket (G86, S88, Y229, E233, P235 and Y253) are arranged in two distinct clusters about the entrance to the hydrophobic pocket. On one side, S88 from the β3/α2 loop is hydrogen bonded (2.6 Å) to the side chain hydroxyl of Y253, while on the opposite side the side chains of Y229 and E233 project into the entrance (Fig  1d) .
Determination of a CDPS crystal structure and localization of putative active site residues facilitates an examination of the CDPS mechanism. Since CDPSs utilize charged tRNA substrates, the enzymes must somehow co-localize two activated amino acids. One possibility is the binding of more than one charged tRNA per CDPSs subunit, with the enzyme catalyzing the formation of a dipeptide intermediate which then cyclizes. A second possibility is that the charged-tRNAs bind to a single site consecutively, with the first charged amino acid passed to an enzyme group by transesterification followed by release of tRNA. The second charged tRNA could then bind the same enzyme surface, followed by formation of dipeptide on the enzyme or the second tRNA.
To test these two possibilities enzyme kinetics and radioactive tagging experiments were performed. Firstly, kinetic parameters were determined for our Rv2275 enzyme preparation. Incubation of Rv2275 with L-Tyr, Tyr-tRNA, EcTyrRS, ATP and MgCl 2 yielded cYY in a time dependent manner ( Supplementary Fig. 5a ) as previously observed 9 . Rv2275 exhibited a K m value of 3.6 ± 0.3 μM for E. coli Tyr-tRNA Tyr and a turnover number of 2.50 ± 0.06 s −1 ( Supplementary Fig. 5b ). The kinetic parameters, particularly the k cat /K m value observed here (0.7×10 6 M −1 sec −1 ) is comparable to the k cat /K m value of LvFemX (0.73×10 6 M −1 sec −1 ) for E. coli Ala-tRNA Ala , an aa-tRNA dependent nonribosomal peptidyltransferase for which the kinetic parameters are known 14 .
Rv2275 was then incubated with substoichiometric amounts of [ 14 C]-Tyr-tRNA Tyr and the reaction mixture was fractionated by anion exchange HPLC to separate tRNA from Rv2275. Approximately 25% of the radiolabel coeluted with the protein (Fig. 2a) , consistent with the formation of a covalent tyrosinoylated enzyme intermediate that is trapped under these conditions. Examination of strictly conserved residues suggested S88 as the likely nucleophile due to its relatively short hydrogen bond (2.6 Å) with the hydroxyl of Y253. Assays using the S88A mutant showed a complete loss of cYY-forming activity, and an abolition of protein radiolabeling ( Fig. 2a; Supplementary Table 3 ).
Several additional mutants were made to examine the roles of conserved residues and to ensure that S88 was indeed the point of covalent attachment. The Y253F mutant retained a small but detectable amount of catalytic activity (200 fold decrease) consistent with the likely role Y253 plays in positioning and increasing the nucleophilicity of the S88 hydroxyl. The Y229F mutant only decreased in activity 20 fold, suggesting the phenolic hydroxyl plays a role in substrate binding. Both the E233A and the E233Q mutants demonstrated a complete loss of cYY-forming activity. The isosteric E233Q mutant was examined for retention of the covalent intermediate by HPLC (Fig. 2a) . The E233Q mutant retained about 55% of the radiolabel amounting to approximately twice as much radiolabel as wild type. These results argue that E233 is not the point of covalent attachment and may play a role in the collapse of the tyrosyl-enzyme ester intermediate. The presence of the early peak (Tyr) in catalytically incompetent S88A and E233Q mutants is due to the hydrolytic instability of aminoacyl-tRNA.
We confirmed the presence of a covalently bound intermediate by isolating the tyrosylenzyme intermediate under two different denaturing conditions. In the first, substoichiometric amounts of [ 14 C]Tyr-tRNA Tyr was mixed with WT Rv2275, E233Q and S88A mutants and the proteins were separated on SDS-PAGE and autoradiographed. Radioactivity is clearly visible associated with WT Rv2275, while the E233Q mutant retained a higher amount of the radiolabel and S88A did not retain any radiolabel (Fig 2b) . In a second experiment, His 6 tagged WT and mutant proteins were similarly radiolabled and bound to Ni-NTA beads. Beads were repeatedly washed with 5M urea. Denatured protein was eluted with imidazole and the radioactivity in the fractions was measured. No radioactivity above background was detected in the imidazole eluate of the S88A mutant. The WT Rv2275 and the E233Q mutant retained 3% and 15% of the total radioactivity, respectively (Supplementary Fig. 6 ). These results confirm the presence of a covalently bound tyrosyl-enzyme intermediate and S88 as the point of covalent attachment.
Based on the structure and our mutational analysis we propose catalysis occurs with the initial binding of Tyr-tRNA Tyr in an orientation such that α-amino group of tyrosine is positioned to allow for interaction with E233 (Fig. 3a) . Nucleophilic attack by the S88 hydroxyl on the ester carbonyl results in the formation of the covalently tyrosinoylated enzyme and free Tyr-tRNA (Fig. 3b) . In order for a second Tyr-tRNA Tyr to bind, the covalently bound tyrosine must swing out of its original binding pocket and the rotation of the side chain of S88 (from chi 1 = 55° to chi1 = 178°) would place the tyrosine in a large secondary surface depression ( Supplementary Fig. 7 ). The formation of radiolabled tyrosinoylated enzyme with the E233Q mutant form of Rv2275 suggests that this initial transesterification chemistry does not require E233. The second Tyr-tRNA Tyr binds and the chemistry here becomes ambiguous. The α-amino group of the enzyme-bound tyrosine could attack the carbonyl ester of the Tyr-tRNA Tyr to generate the enzyme-bound dipeptide or the α-amino group of the tRNA-bound tyrosine could attack the enzyme bound tyrosine to generate the tRNA-bound dipeptide. The structure suggests that the latter is more likely, given the need for a general base to deprotonate the α-amino group to attack the enzyme ester bond. Once the first peptide bond is formed, the second chemical step occurs, and in this step E233 could assist in protonating the product 3′-hydroxyl group of tRNA. It is unclear how the protein plays a role in orienting the dipeptide to promote this cyclization chemistry, and although the intramolecular cyclization of a dipeptide ester is facile, it requires that the dipeptide be in a cis conformation to place the amine in proximity to the ester 15 , 16 .
In conclusion, the structural determination of Rv2275 is the first of a member of the cyclodipeptide synthetase family and unexpectedly resembles the catalytic domain of class I tRNA-synthetases. However, Rv2275 lacks an ATP binding site, an anticodon binding domain and exhibits a different dimerization interface. The reaction proceeds via a pingpong kinetic mechanism with a unique intermediate produced by an aminoacyl transesterification reaction. Future structural and bioinformatics studies may shed light on the nature of their evolution; did they evolve from fully functional tRNA-synthetases by losing features, or do they represent a divergence from a common primitive tRNA synthetase ancestor? Shown is the mechanism where the dipeptide ester is formed on the tRNA. An equivalent argument could be made for the formation of the dipeptide ester of S88, however the roles of the enzyme groups would not change.
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